Table 3. Characteristics on admission of primary VL patients who did or did not have record of subsequent relapse.
| Primary VL patients who subsequently relapsed (N = 166) | Primary VL patients who had no record of subsequent relapse (N = 7,924) | P-value* | ||
| Age group | <5 years | 21.1% | 17.7% | 0.5 |
| 5–19 years | 45.8% | 46.3% | ||
| >19 years | 33.1% | 36.0% | ||
| Sex | Male | 58.4% | 52.9% | 0.2 |
| Treatment centre | Lankien | 77.7% | 60.4% | <0.001 |
| Other | 22.3% | 39.6% | ||
| Mean BMI (patients >19 years) (kg/m2) | (n = 54) 15.50 | (n = 2,525) 15.57 | 0.8 | |
| Mean BMI-for-age Z-score (patients 5–19 years) | (n = 65) −3.48 | (n = 2,882) −3.40 | 0.6 | |
| Mean WFH Z-score (patients <5 years) | (n = 30) −2.65 | (n = 1,254) −2.68 | 0.9 | |
| Malnourished (Z-score<−3 or BMI<14kg/m2) | 26.8% | 28.6% | 0.6 | |
| Missing height or weight data | 10.2% | 15.9% | 0.01 | |
| Mean admission hemoglobin (g/dl) | 8.26 | 8.66 | 0.1 | |
| Missing hemoglobin data | 67.5% | 68.4% | 0.8 | |
| Mean duration of illness (months) | 1.73 | 1.88 | 0.2 | |
| Missing duration of illness data | 1.8% | 3.1% | 0.4 | |
| Admission spleen size (Hackett Grade) | 0 | 3.0% | 8.1% | 0.002 |
| 1 | 20.5% | 25.0% | ||
| 2 | 44.0% | 42.8% | ||
| ≥3 | 31.3% | 20.8% | ||
| Missing | 1.2% | 3.4% | ||
| Walking status | Unassisted | 22.9% | 23.1% | 1.0 |
| With a stick | 48.2% | 49.2% | ||
| Assisted/Stretcher | 15.7% | 14.8% | ||
| Missing | 13.3% | 13.0% | ||
| Drug used for primary VL | SSG | 27.1% | 43.9% | <0.001 |
| SSG/PM | 70.5% | 54.8% | ||
| Other/CAPST | 0.0% | 0.5% | ||
| Missing | 2.4% | 0.8% | ||
| Vomiting during treatment | 28.3% | 28.2% | 1.0 | |
| Bleeding during treatment | 2.4% | 3.8% | 0.4 | |
| Diarrhoea during treatment | 34.3% | 35.2% | 0.8 |
*Student's t-test for difference between mean values, Chi-squared test for differences in proportions.